SCHEMBL2474087

SCHEMBL2474087

Cc1cc(C(C)(C)C)cc(Cl)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.46
GABRB2 P47870 1/20 0.46
ACLY P53396 1/20 0.44
CYP2C19 P33261 4/20 0.43
CYP2C9 P11712 3/20 0.43
CYP1A2 P05177 2/20 0.43
POLB P06746 2/20 0.43
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
TP53 P04637 1/20 0.40
HIF1A Q16665 1/20 0.40
CYP2D6 P10635 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 3/20 0.39
CA2 P00918 2/20 0.39
TTR P02766 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321695 0.88 GABRA1 (0.52) GABRA1GABRB2ACLYCYP2C19CYP2C9
SCHEMBL297381 0.86 HSD17B10 (0.46) CYP2C19CYP2C9CYP1A2SMN1; SMN2ESR1
SCHEMBL31287202 0.86 HSD17B10 (0.46) CYP2C19CYP2C9CYP1A2SMN1; SMN2ESR1
SCHEMBL29065613 0.86 GABRA1 (0.50) GABRA1GABRB2ACLYCYP2C19CYP2C9
SCHEMBL201609 0.83 GABRA1 (0.57) GABRA1GABRB2CYP2C19CYP2C9CYP1A2
SCHEMBL23542361 0.82 ALDH1A1 (0.46) GABRA1GABRB2ACLYCYP2C19CYP2C9
SCHEMBL28119481 0.80 GABRA1 (0.55) GABRA1GABRB2CYP2C19CYP2C9CYP1A2
SCHEMBL20371164 0.80 CA2 (0.48) GABRA1GABRB2ACLYCYP2C19CYP2C9
SCHEMBL12635966 0.80 PDE2A (0.43) GABRB2POLBESR1ESR2ALDH1A1
SCHEMBL814586 0.78 TSHR (0.54) GABRA1GABRB2ACLYCYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507717-B2 Production of substituted phenylene aromatic diesters DOW GLOBAL TECHNOLOGIES LLC (US) 2013-08-13 US claimed
US-20100174105-A1 Production of Substituted Phenylene Aromatic Diesters W.R. GRACE & CO.-CONN. 2010-07-08 US claimed
US-8507717-B2 Production of substituted phenylene aromatic diesters DOW GLOBAL TECHNOLOGIES LLC (US) 2013-08-13 US disclosed
EP-2373604-A2 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-12 EP disclosed
WO-2010078512-A2 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed
US-20100174105-A1 Production of Substituted Phenylene Aromatic Diesters W.R. GRACE & CO.-CONN. 2010-07-08 US disclosed
US-7569725-B2 2-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]-5-phenoxybenzamide; therapeutic use as anti-cancer agents, as well as other therapeutic agents, for example, as anti-fertility agents BRITSOL-MYERS SQUIBB COMPANY (US) 2009-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100174105-A1 Production of Substituted Phenylene Aromatic Diesters DDT, COMT, DDC GABRA1 2114/4885GABRB2 1893/4885ACLY 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.